Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more
Market Cap & Net Worth: Chi Sheng Chemical (4111)
Chi Sheng Chemical (TWO:4111) has a market capitalization of $52.99 Million (NT$1.75 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #22069 globally and #1246 in its home market, demonstrating a -2.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chi Sheng Chemical's stock price NT$29.30 by its total outstanding shares 59832150 (59.83 Million).
Chi Sheng Chemical Market Cap History: 2015 to 2026
Chi Sheng Chemical's market capitalization history from 2015 to 2026. Data shows growth from $36.07 Million to $52.99 Million (5.31% CAGR).
Chi Sheng Chemical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chi Sheng Chemical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Chi Sheng Chemical's market cap is 0.04 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.45x
Chi Sheng Chemical's market cap is 0.45 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $36.76 Million | $1.04 Billion | $81.74 Million | 0.04x | 0.45x |
| 2018 | $37.43 Million | $967.40 Million | $42.25 Million | 0.04x | 0.89x |
| 2019 | $39.70 Million | $1.02 Billion | $72.45 Million | 0.04x | 0.55x |
| 2020 | $39.73 Million | $979.36 Million | $59.14 Million | 0.04x | 0.67x |
| 2021 | $40.08 Million | $1.02 Billion | $80.75 Million | 0.04x | 0.50x |
| 2022 | $49.01 Million | $1.14 Billion | $154.01 Million | 0.04x | 0.32x |
| 2023 | $48.19 Million | $1.06 Billion | $68.67 Million | 0.05x | 0.70x |
| 2024 | $50.27 Million | $1.17 Billion | $110.63 Million | 0.04x | 0.45x |
Competitor Companies of 4111 by Market Capitalization
Companies near Chi Sheng Chemical in the global market cap rankings as of March 18, 2026.
Key companies related to Chi Sheng Chemical by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Chi Sheng Chemical Historical Marketcap From 2015 to 2026
Between 2015 and today, Chi Sheng Chemical's market cap moved from $36.07 Million to $ 52.99 Million, with a yearly change of 5.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$52.99 Million | -0.51% |
| 2025 | NT$53.26 Million | +5.94% |
| 2024 | NT$50.27 Million | +4.32% |
| 2023 | NT$48.19 Million | -1.66% |
| 2022 | NT$49.01 Million | +22.28% |
| 2021 | NT$40.08 Million | +0.88% |
| 2020 | NT$39.73 Million | +0.09% |
| 2019 | NT$39.70 Million | +6.06% |
| 2018 | NT$37.43 Million | +1.82% |
| 2017 | NT$36.76 Million | +13.14% |
| 2016 | NT$32.49 Million | -9.93% |
| 2015 | NT$36.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Chi Sheng Chemical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.99 Million USD |
| MoneyControl | $52.99 Million USD |
| MarketWatch | $52.99 Million USD |
| marketcap.company | $52.99 Million USD |
| Reuters | $52.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.